Literature DB >> 3262334

Deep vein thrombosis: prophylaxis in acute spinal cord injured patients.

G J Merli1, G J Herbison, J F Ditunno, H H Weitz, J H Henzes, C H Park, M M Jaweed.   

Abstract

The purpose of this prospective, randomized study was to evaluate the efficacy of low-dose heparin, alone or in combination with electric stimulation, in the prevention of deep vein thrombosis (DVT) in C2 to T11 motor complete and incomplete-preserved motor, nonfunctional spinal cord injured patients. The tibialis anterior and gastrocnemius-soleus muscle groups were stimulated bilaterally, using 50 microsecond pulses given at 10Hz with a four-second "on" and an eight-second "off" cycle for 23 hours daily over a 28-day period. Forty-eight patients, less than two weeks after injury, were randomly assigned to saline placebo (n = 17), low-dose heparin (5,000U, subcutaneous every eight hours) (n = 16), and low-dose heparin plus electric stimulation (n = 15). A normal 125-I fibrinogen scan and impedance plethysmography were required for entry into the study. Surveillance for DVT was evaluated by daily 125-I fibrinogen scanning. Venography was performed to confirm a positive impedance plethysmography and/or 125-I fibrinogen scanning tests for two consecutive days and at the completion of the study. The incidence of DVT was 8 of 17 in the placebo group, 8 of 16 in the low-dose heparin group, and 1 of 15 in the electric stimulation plus low-dose heparin group. The use of electric stimulation plus low-dose heparin significantly (p less than 0.05) decreased the incidence of DVT compared to the other treatments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262334

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  12 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Fibrinogen metabolism in patients with spinal cord injury.

Authors:  James H Frisbie
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Deep vein thrombosis in patients with spinal cord injury.

Authors:  A Perkash; I Perkash
Journal:  West J Med       Date:  1990-10

4.  Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed.: Consortium for Spinal Cord Medicine.

Authors: 
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

Review 5.  Venous thromboembolism after spinal cord injury.

Authors:  Robert W Teasell; Jane T Hsieh; Jo-Anne L Aubut; Janice J Eng; Andrei Krassioukov; Linh Tu
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

Review 6.  Prophylaxis of venous thromboembolism in brain tumor patients.

Authors:  M G Hamilton; R D Hull; G F Pineo
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  Neuromuscular electrical stimulation for the prevention of venous thromboembolism.

Authors:  Shahab Hajibandeh; Shahin Hajibandeh; George A Antoniou; James Rh Scurr; Francesco Torella
Journal:  Cochrane Database Syst Rev       Date:  2017-11-21

8.  Incidence of deep vein thrombosis after spinal cord injury in Korean patients at acute rehabilitation unit.

Authors:  Jong Geol Do; Du Hwan Kim; Duk Hyun Sung
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

Review 9.  Electrical muscle stimulation in thomboprophylaxis: review and a derived hypothesis about thrombogenesis-the 4th factor.

Authors:  Christos Stefanou
Journal:  Springerplus       Date:  2016-06-24

10.  A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Type and Timing of Anticoagulant Thromboprophylaxis.

Authors:  Michael G Fehlings; Lindsay A Tetreault; Bizhan Aarabi; Paul Anderson; Paul M Arnold; Darrel S Brodke; Anthony S Burns; Kazuhiro Chiba; Joseph R Dettori; Julio C Furlan; Gregory Hawryluk; Langston T Holly; Susan Howley; Tara Jeji; Sukhvinder Kalsi-Ryan; Mark Kotter; Shekar Kurpad; Brian K Kwon; Ralph J Marino; Allan R Martin; Eric Massicotte; Geno Merli; James W Middleton; Hiroaki Nakashima; Narihito Nagoshi; Katherine Palmieri; Anoushka Singh; Andrea C Skelly; Eve C Tsai; Alexander Vaccaro; Jefferson R Wilson; Albert Yee; James S Harrop
Journal:  Global Spine J       Date:  2017-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.